品質管理
弊社はライフサイエンスにおける研究、開発、製造の世界的なリーディングサプライヤーになるため日々精進しています。我々の目標を達成するためには顧客の皆様の要求を満たす必要があります。 優れた品質と品質保証基準を確立・維持することにより、この目標を実現します。
SelleckはPD1/PDL1治療用抗体の販売を開始しました！（Pembrolizumab，Atezolizumab，Nivolumab）
- ホームページ
- 阻害剤
研究分野別
- PI3K/Akt/mTOR
- Epigenetics
- Methylation
- Immunology & Inflammation
- Protein Tyrosine Kinase
- Angiogenesis
- Apoptosis
- Autophagy
- ER stress & UPR
- JAK/STAT
- MAPK
- Cytoskeletal Signaling
- Cell Cycle
- HTS化合物ライブラリー
- FDA-approved Drug Library
- Clinical Compound Library
- Bioactive Compound Library-I
- Bioactive Compound Library-Ⅱ（Provided by Pfizer）
- Kinase Inhibitor Library
- Express-Pick Library (Provided by Pfizer)
- Natural Product Library
- Human Endogenous Metabolite Library
- Metabolism Compound Library
- Target Selective Inhibitor Library
- Epigenetics Compound Library
- Stem Cell Signaling Compound Library
- Inhibitor Library
- Apoptosis Compound Library
- FDA-approved Drug Library(Simplified Edition)
- GPCR Compound Library
- Cambridge Cancer Compound Library
- Immunology/Inflammation Compound Library
- Drug Repurposing Library
- Pfizer Licensed Compound Library
- MAPK Inhibitor Library
- Fragment Library New
- Neuronal Signaling Compound Library
- PI3K/Akt Inhibitor Library
- Anti-diabetic Compound Library
- Anti-infection Compound Library
- Anti-cancer Compound Library
- Tyrosine Kinase Inhibitor Library
- Ion Channel Ligand Library
- Protease Inhibitor Library
- Autophagy Compound Library
- Bioactive Compound Library(Simplified Edition)
- HTS Library for Drug Discovery (Provided by Pfizer)
- DNA Damage/DNA Repair Library New
- CNS-Penetrant Compound Library New
- Small Molecule Immuno-Oncology Compound Library New
- Histone modification compound library New
- Cell Cycle library New
- Angiogenesis Related Library New
- Antibiotics Library New
- JAK/STAT compound library New
- NF-κB Signaling Compound Library New
- TGF-beta/Smad compound library New
- 治療用抗体
- 新製品
- お問い合わせ
